Reprint
Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition
Edited by
December 2023
286 pages
- ISBN978-3-0365-9557-3 (Hardback)
- ISBN978-3-0365-9556-6 (PDF)
This book is a reprint of the Special Issue Polymers Enhancing Bioavailability in Drug Delivery, 2nd Edition that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
This Special Issue provides an update on the state of the art and current trends in polymeric drug delivery systems specifically designed for improving drug bioavailability. The multiple contributions received further strengthen the role of polymers in modern drug delivery and targeting, illustrating the different approaches possible and unveiling what the future may bring.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
Histoplasma capsulatum; PLGA; Itraconazole; macrophage; functionalized nanoparticle; F4/80 receptor; rutin; nanocrystals; anti-inflammatory; hydroxypropyl beta-cyclodextrin; nanoparticles; budesonide; nanoparticles; chitosan; colon delivery; eudragit; pellets; ferrisilicate; PEG; insulin; encapsulation; diabetic mellitus; polypeptides; drug delivery; nanoparticles; doxorubicin; cancer; topology of poly-l-cystein; antimicrobial; antifouling; drug delivery; pH sensitivity; zwitterionic polymers; gamma radiation; copolyester; SPION; cysteine; bioconjugation; and enzymatic release; polymeric nanoparticles; drug delivery and targeting; ocular posterior segment; oxidative stress; retinal degeneration; nerve growth factor; peanut agglutinin; zebrafish; molecular dynamics simulation; interaction energy; hydrogen bonding; solid dispersion; hot melt extrusion; amorphous formulation; tacrolimus; sucrose acetate isobutyrate; amorphous solid dispersion; dissolution; stability; pharmacokinetics; phytomedicine; nanosponges; lactoferrin; bioavailability; MDA-MB-231 cells; caspase-3; cyclin-D1; dendrimers; Janus nanoparticles; drug delivery; biocompatibility; nanoformulation; pharmaceuticals; 3D printing; hybrid scaffold; polycaprolactone; chitosan; vancomycin; mesenchymal stem cells; tissue engineering; drug delivery systems (DDSs); osteomyelitis; n/a